MINUTES
About Minutes
Back to latest

EconomyLilly to buy Calytrix Bio for up to $1.5 billion

Privately held biotech Calytrix Bio said on Monday that Eli Lilly has agreed to acquire it for up to $1.5 billion in cash, expanding development of treatments for rare blood cancers.

Eli Lillyacquisitionbiotechnologyrare blood cancers

RReuters★★☆☆☆2026-11-16 12:35Original

Lilly to buy Calytrix Bio for up to $1.5 billion
Lilly to buy Calytrix Bio for up to $1.5 billionEconomy